Anorectic Drugs: Drug Policy Making at the State Level
- 1 May 1988
- journal article
- research article
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 28 (5) , 395-400
- https://doi.org/10.1002/j.1552-4604.1988.tb05747.x
Abstract
This study outlines the attempts of four states (Louisiana, Kansas, Wisconsin, and Michigan) to restrict anorectic prescriptions. The actions in these four states exemplify the various mechanisms used in regulating anorectics, ranging from educational efforts to legislative enactments. We examine the evidence used in promulgating these policies and review some of the current literature on the safety and efficacy of anorectics. Despite the existence of evidence demonstrating the safety and efficacy of anorectics, the states seem to be moving toward more severe restrictions, in contrast to the federal regulatory agencies.This publication has 5 references indexed in Scilit:
- The involvement of brain serotonin in excessive carbohydrate snacking by obese carbohydrate craversJournal of the American Dietetic Association, 1984
- A Double-blind Clinical Trial in Weight ControlArchives of internal medicine (1960), 1984
- A double-blind clinical trial in weight control. Use of fenfluramine and phentermine alone and in combinationArchives of internal medicine (1960), 1984
- Restricting AmphetaminesPublished by American Medical Association (AMA) ,1981
- Predicting the Abuse Liability of Drugs with Animal Drug Self-Administration Procedures: Psychomotor Stimulants and HallucinogensPublished by Elsevier ,1979